Skip to main navigation
Go back to homepage
  • About Us
    • Overview
    • Our Values
    • Leadership
    • Board of Directors
  • Focus
    • Overview
    • PAH
    • Inhaled Treprostinil
  • Pipeline & Products
    • Our Pipeline
    • L606
    • Clinical Trials
    • Commercial Products
    • Publications
  • Technology
    • Overview
    • PRINT
  • Patients
  • Medical Professionals
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Analyst Coverage
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • SEC Filings
    • IR Resources
      • Investor FAQs
      • IR Contact
      • Email Alerts
      • Proxy Online
  • Careers
    • Overview
    • Our Values
    • Employee Benefits
    • Career Opportunities

Publications

Pioneers in rare cardiopulmonary disease

Explore the science behind our clinical trials.

Search

September 8, 2026
| Poster
Vincent Cottin, Sanjeev Khindri, Savan Patel, Renee Jones, Rajeev Saggar
Re-Spire: A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Pulmonary Hypertension With Interstitial Lung Disease (PH-ILD) Participants
Barcelona
June 12, 2026
| Poster
Seth Hall, MBA, RRT, RRT-ACCS, RRT-NPS
The Invisible Burden: Mental Health Challenges Facing Caregivers of Patients with Pulmonary Hypertension
Dallas, Texas
June 12, 2026
| Poster
Diana Gritsenko, Brittany Hardek, Savan Patel, Ashley M. West
The PHriendly Neighborhood Pharmacist: Mapping the Pharmacist’s Role in Pulmonary Hypertension Care Teams
Dallas, Texas
February 23, 2026
| Publication
Hall, S.
The Essential Role of Caregivers in Pulmonary Hypertension: A Patient Advocacy Perspective on Support, Resources, and the Unique Challenges Facing Families.
Respiratory Therapy Vol 21 No. 2 Spring 2026
January 30, 2026
| Poster
R. Restrepo-Jaramillo, A. Muralidhar, M. Trivieri, C. Burger, J. Elwing, J. Feldman, S. Shapiro, J. Yau, P. Kan, A. Leblond, S. Khindri, R. Saggar
Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
Dublin, Ireland
May 20, 2025
| Poster
Flores, S.M., Patel, S., Estrada, R.
Transitioning From Parenteral Treprostinil to LIQ861 in a Patient With PAH
San Francisco, CA
March 5, 2025
| Publication
Hall, S., Ravichandran, V., Patel, S., Gwyn, G.
The Evolution of Inhaled Therapies: Advancements in Respiratory Disease Management. Respiratory Therapy: The Journal of Pulmonary Technique. 2025; 20(2)
May 22, 2024
| Poster
Habib, N., Restrepo, R., Trivieri, M., Shapiro, S., Burger, C., Patel, S., Galloway, A., Kan, P., Saggar, R.
An Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD. 2024 American Thoracic Society International Conference
San Diego, CA
February 2, 2024
| Poster
Tully, J., Saggar, R., Prabel, J., Garcia, A., Patel, S., Chen, K., Kan, P.
Clinical Pharmacokinetics of an Extended-Release Formulation of Inhaled Liposomal Treprostinil (L606) to Reduce Dosing Frequency. Pulmonary Vascular Research Institute (PVRI) 2024 Annual Congress
London
May 22, 2023
| Poster
Burger, C.D., Sahay, S., Patel, S., Galloway, A., MacLennan, D., Elwing, M.
Exploratory Efficacy Analysis of INSPIRE Open-Label Extension Study With Inhaled Treprostinil (YUTREPIA™). American Thoracic Society International Conference
Washington D.C.
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Go back to homepage

Socials

  • Science
    • Pipeline & Products
    • Technology
    • Publications
    • Report an Adverse Event
  • Company
    • About
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Corporate Social Responsibility
    • Expanded Access Program
    • Financial Information

Copyright © 2026 Liquidia Corporation. All Rights Reserved.

  • Accessibility
  • Cookie Policy
  • Legal
  • Privacy Policy